PascalFr.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « PascalFr.i » - entrée « Neuroprotection »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Neuroprotecteur < Neuroprotection < Neuropsychiatrie  Facettes :

List of bibliographic references indexed by Neuroprotection

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000B91 (2014) C. H. Carriere [Canada] ; N. H. Kang [Canada] ; L. P. Niles [Canada]NEUROPROTECTION BY VALPROIC ACID IN AN INTRASTRIATAL ROTENONE MODEL OF PARKINSON'S DISEASE
001037 (2013) Roger S. Mcintyre [Canada] ; Alissa M. Powell [Canada] ; Oksana Kaidanovich-Beilin [Canada] ; Joanna K. Soczynska [Canada] ; Mohammad Alsuwaidan [Canada] ; Hanna O. Woldeyohannes [Canada] ; Ashley S. Kim [Canada] ; L. Ashley Gallaugher [Canada]The neuroprotective effects of GLP-1: Possible treatments for cognitive deficits in individuals with mood disorders
001496 (2012) Maria Xilouri [Grèce] ; Elli Kyratzi [Grèce] ; Pothitos M. Pitychoutis [Grèce] ; Zoi Papadopoulou-Daifoti [Grèce] ; Celine Perier [Espagne] ; Miquel Vila [Espagne] ; Matina Maniati [Grèce] ; Ayse Ulusoy [Suède] ; Deniz Kirik [Suède] ; David S. Park [Canada] ; Keiji Wada [Japon] ; Leonidas Stefanis [Grèce]Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system
001548 (2012) Jihane Ismaili [Canada] ; Martin Boisvert [Canada] ; Fanny Longpre [Canada] ; Julie Carange [Canada] ; Céline Le Gall [Canada] ; Maria-Grazia Martinoli [Canada] ; Benoit Daoust [Canada]Brassinosteroids and analogs as neuroprotectors: Synthesis and structure-activity relationships
001923 (2011) C. Gibrat [Canada] ; F. Cicchetti [Canada]Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases : THE NEUROBIOLOGY OF NEURODEGENERATIVE DISORDER: FROM BASIC TO CLINICAL RESEARCH
001956 (2011) Ngoc-Duc Doan [Canada] ; Steve Bourgault [Canada] ; Agnieszka Dejda [Canada] ; Myriam Letourneau [Canada] ; Michel Detheux [Belgique] ; David Vaudry [Canada, France] ; Hubert Vaudry [Canada, France] ; David Chatenet [Canada] ; Alain Fournier [Canada]Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects
001D30 (2010) C. Gibrat [Canada] ; M. Bousquet [Canada] ; M. Saint-Pierre [Canada] ; D. Levesque [Canada] ; F. Calon [Canada] ; C. Rouillard [Canada] ; F. Cicchetti [Canada]Cystamine prevents MPTP-induced toxicity in young adult mice via the up-regulation of the brain-derived neurotrophic factor
002079 (2009) M. Bousquet [Canada] ; C. Gibrat [Canada] ; M. Saint-Pierre [Canada] ; C. Julien [Canada] ; F. Calon [Canada] ; F. Cicchetti [Canada]Modulation of brain-derived neurotrophic factor as a potential neuroprotective mechanism of action of omega-3 fatty acids in a parkinsonian animal model
002553 (2007) Rohita Sharma [Canada] ; Catherine R. Mcmillan [Canada] ; Lennard P. Niles [Canada]Neural stem cell transplantation and melatonin treatment in a 6‐hydroxydopamine model of Parkinson’s disease
002638 (2007) Mélanie Bourque [Canada] ; BIN LIU [États-Unis] ; Dean E. Dluzen [États-Unis] ; Therese Di Paolo [Canada]Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity
002915 (2006) Rohita Sharma [Canada] ; Catherine R. Mcmillan [Canada] ; Catherine C. Tenn [Canada] ; Lennard P. Niles [Canada]Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease
002B12 (2005) V. F. Rafuse [Canada] ; P. Soundararajan [Canada] ; C. Leopold [Canada] ; H. A. Robertson [Canada]Neuroprotective properties of cultured neural progenitor cells are associated with the production of sonic hedgehog
002B24 (2005) Bianca Marchetti [Italie] ; Pier Andrea Serra [Italie] ; Cataldo Tirolo [Italie] ; Francesca L'Episcopo [Italie] ; Salvo Caniglia [Italie] ; Florinda Gennuso [Italie] ; Nuccio Testa [Italie] ; Egidio Miele [Italie] ; Speranza Desole [Italie] ; Nicholas Barden [Canada] ; Maria Concetta Morale [Italie]Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental parkinsonism : pivotal role for glia-neuron interactions
002D15 (2004) S. Mccarthy [Canada] ; M. Somayajulu [Canada] ; M. Sikorska [Canada] ; H. Borowy-Borowski [Canada] ; S. Pandey [Canada]Paraquat induces oxidative stress and neuronal cell death; neuroprotection by water-soluble Coenzyme Q10
002D18 (2004) M. O. Poulter [Canada] ; K. B. Payne [Canada] ; J. P. Steiner [États-Unis]Neuroimmunophilins: A novel drug therapy for the reversal of neurodegenerative disease?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Neuroprotection" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Neuroprotection" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Neuroprotection
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022